P938: CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE CONSOLIDATION IN MYELOMA PATIENTS WITH A POSITIVE FDG PET/CT AFTER UPFRONT AUTOLOGOUS STEM CELL TRANSPLANTATION: A PHASE II STUDY (CONPET)
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-06-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000846620.98940.79 |
_version_ | 1827336340289617920 |
---|---|
author | J. N. Nørgaard N. Abildgaard A. Lysén G. Tsykunova A. J. Vangsted C. Joao N. Remen L. Osnes J. P. Connelly M.-E. R. Revheim F. Schjesvold |
author_facet | J. N. Nørgaard N. Abildgaard A. Lysén G. Tsykunova A. J. Vangsted C. Joao N. Remen L. Osnes J. P. Connelly M.-E. R. Revheim F. Schjesvold |
author_sort | J. N. Nørgaard |
collection | DOAJ |
first_indexed | 2024-03-07T18:30:01Z |
format | Article |
id | doaj.art-754b70b413ea4335b56f9be28bc726ef |
institution | Directory Open Access Journal |
issn | 2572-9241 |
language | English |
last_indexed | 2024-03-07T18:30:01Z |
publishDate | 2022-06-01 |
publisher | Wiley |
record_format | Article |
series | HemaSphere |
spelling | doaj.art-754b70b413ea4335b56f9be28bc726ef2024-03-02T06:40:49ZengWileyHemaSphere2572-92412022-06-01682882910.1097/01.HS9.0000846620.98940.79202206003-00828P938: CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE CONSOLIDATION IN MYELOMA PATIENTS WITH A POSITIVE FDG PET/CT AFTER UPFRONT AUTOLOGOUS STEM CELL TRANSPLANTATION: A PHASE II STUDY (CONPET)J. N. Nørgaard0N. Abildgaard1A. Lysén2G. Tsykunova3A. J. Vangsted4C. Joao5N. Remen6L. Osnes7J. P. Connelly8M.-E. R. Revheim9F. Schjesvold101 Oslo Myeloma Center, Department of Hematology, Oslo University Hospital4 Department of Hematology, Odense University Hospital1 Oslo Myeloma Center, Department of Hematology, Oslo University Hospital6 Division of Hematology, Haukeland University Hostpital, Bergen, Norway7 Departmen of Hematology, Rigshospitalet, Copenhagen, Denmark8 Department of Hematology, Champalimaud Centre for the Unknown, Lisboa, Portugal1 Oslo Myeloma Center, Department of Hematology, Oslo University Hospital9 Department of Immunology10 Division for Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway2 Institute of Clinical Medicine1 Oslo Myeloma Center, Department of Hematology, Oslo University Hospitalhttp://journals.lww.com/10.1097/01.HS9.0000846620.98940.79 |
spellingShingle | J. N. Nørgaard N. Abildgaard A. Lysén G. Tsykunova A. J. Vangsted C. Joao N. Remen L. Osnes J. P. Connelly M.-E. R. Revheim F. Schjesvold P938: CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE CONSOLIDATION IN MYELOMA PATIENTS WITH A POSITIVE FDG PET/CT AFTER UPFRONT AUTOLOGOUS STEM CELL TRANSPLANTATION: A PHASE II STUDY (CONPET) HemaSphere |
title | P938: CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE CONSOLIDATION IN MYELOMA PATIENTS WITH A POSITIVE FDG PET/CT AFTER UPFRONT AUTOLOGOUS STEM CELL TRANSPLANTATION: A PHASE II STUDY (CONPET) |
title_full | P938: CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE CONSOLIDATION IN MYELOMA PATIENTS WITH A POSITIVE FDG PET/CT AFTER UPFRONT AUTOLOGOUS STEM CELL TRANSPLANTATION: A PHASE II STUDY (CONPET) |
title_fullStr | P938: CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE CONSOLIDATION IN MYELOMA PATIENTS WITH A POSITIVE FDG PET/CT AFTER UPFRONT AUTOLOGOUS STEM CELL TRANSPLANTATION: A PHASE II STUDY (CONPET) |
title_full_unstemmed | P938: CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE CONSOLIDATION IN MYELOMA PATIENTS WITH A POSITIVE FDG PET/CT AFTER UPFRONT AUTOLOGOUS STEM CELL TRANSPLANTATION: A PHASE II STUDY (CONPET) |
title_short | P938: CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE CONSOLIDATION IN MYELOMA PATIENTS WITH A POSITIVE FDG PET/CT AFTER UPFRONT AUTOLOGOUS STEM CELL TRANSPLANTATION: A PHASE II STUDY (CONPET) |
title_sort | p938 carfilzomib lenalidomide dexamethasone consolidation in myeloma patients with a positive fdg pet ct after upfront autologous stem cell transplantation a phase ii study conpet |
url | http://journals.lww.com/10.1097/01.HS9.0000846620.98940.79 |
work_keys_str_mv | AT jnnørgaard p938carfilzomiblenalidomidedexamethasoneconsolidationinmyelomapatientswithapositivefdgpetctafterupfrontautologousstemcelltransplantationaphaseiistudyconpet AT nabildgaard p938carfilzomiblenalidomidedexamethasoneconsolidationinmyelomapatientswithapositivefdgpetctafterupfrontautologousstemcelltransplantationaphaseiistudyconpet AT alysen p938carfilzomiblenalidomidedexamethasoneconsolidationinmyelomapatientswithapositivefdgpetctafterupfrontautologousstemcelltransplantationaphaseiistudyconpet AT gtsykunova p938carfilzomiblenalidomidedexamethasoneconsolidationinmyelomapatientswithapositivefdgpetctafterupfrontautologousstemcelltransplantationaphaseiistudyconpet AT ajvangsted p938carfilzomiblenalidomidedexamethasoneconsolidationinmyelomapatientswithapositivefdgpetctafterupfrontautologousstemcelltransplantationaphaseiistudyconpet AT cjoao p938carfilzomiblenalidomidedexamethasoneconsolidationinmyelomapatientswithapositivefdgpetctafterupfrontautologousstemcelltransplantationaphaseiistudyconpet AT nremen p938carfilzomiblenalidomidedexamethasoneconsolidationinmyelomapatientswithapositivefdgpetctafterupfrontautologousstemcelltransplantationaphaseiistudyconpet AT losnes p938carfilzomiblenalidomidedexamethasoneconsolidationinmyelomapatientswithapositivefdgpetctafterupfrontautologousstemcelltransplantationaphaseiistudyconpet AT jpconnelly p938carfilzomiblenalidomidedexamethasoneconsolidationinmyelomapatientswithapositivefdgpetctafterupfrontautologousstemcelltransplantationaphaseiistudyconpet AT merrevheim p938carfilzomiblenalidomidedexamethasoneconsolidationinmyelomapatientswithapositivefdgpetctafterupfrontautologousstemcelltransplantationaphaseiistudyconpet AT fschjesvold p938carfilzomiblenalidomidedexamethasoneconsolidationinmyelomapatientswithapositivefdgpetctafterupfrontautologousstemcelltransplantationaphaseiistudyconpet |